// App-Quantinova.ai

TCT-184 : Late Adverse Events After Implantation of Sirolimus-eluting Stent and Bare-metal Stent: 4-7 years follow-up of the CREDO-Kyoto Registry Cohort-2

Researchers

Presenter

  • Masahiro Natsuaki

Principal Investigators

  • Takeshi Morimoto

  • Yutaka Furukawa

  • Yoshihisa Nakagawa

  • Kazushige Kadota

  • Masashi Iwabuchi

  • Takeshi Kimura

Medical Centers

  • Kobe City Medical Center General Hospital, Kobe, Japan

  • Kokura memorial hospital, Kitakyusyu, Japan

  • Kyoto University, Kyoto, Japan

  • Kinki University, Osaka, Japan

  • Tenri Hospital, Tenri, Japan

  • Kurashiki Central Hospital, Okayama-ken Kurashiki-shi, Japan

  • Saiseikai Fukuoka General Hospital, Fukuoka, Japan

Locations

  • Japan

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

Disease

  • Myocardial infarction

  • Angina

  • Venous thrombosis

  • Coronary Artery Disease

Biomarkers

  • N/A

Drug/Treatment

  • sirolimus

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved